Program

5th UpDate on Hepatology Course, Bucharest 26th-27th April 2018 

Up-Date on Hepatology 2018

„Best Practices in Clinical Hepatology”

 

26 April 2018: Best Practices in Viral Hepatitis

8.00-9.45 Registration & Welcome

9.45-10.00 Introduction

 

10.00-11.20 Best practices in HCV therapy in 2018
Chair: Mircea Diculescu, Susanne Beckebaum

10.00-10.20 Noninvasive assessment of liver fibrosis in HCV patients before and after DAAs
Ioan Sporea,Timisoara, Romania

10.20-10.40 Follow-up of patients with advanced liver disease after virological cure
Liana Gheorghe, Bucharest, Romania

10.40-11.00 Impact of DAA therapy on liver transplantation
Susanne Beckebaum, Muenster, Germany

11.00-11.20 The next wave of HCV therapy and its impact on treatment strategies
Nancy Reau, Chicago, USA
 

11.20-12.20 Overlooked disorders in hepatology
Chair: Speranta Iacob, Hartmut Schmidt

11.20-11.40 Polycystic liver disease
Hartmut Schmidt, Muenster, Germany

11.40-12.00 Wilson disease – a diagnostic challenge
Razvan Iacob,  Bucharest, Romania

12.00-12.20 Liver involvement in amyloidosis
Daniel Coriu, Sorina Badelita, Andreea Jercan, Speranta Iacob, Bucharest, Romania

 

12.20-12.50 State of the Art Lecture
Chair: Carmen Fierbinteanu

NAFLD: the local perception of a global problem
Vlad Ratziu, Paris, France

 
13.00-14.00 Lunch

14.00-14.40
Satelite Symposium AbbVie
„Challenges in treating my HCV patients”
Speaker: Liana Gheorghe, Bucharest, Romania
 

14.40-16.20 Challenging issues in viral hepatitis
Chair: Oliviu Pascu, Ferruccio Bonino

14.40-15.00 Changing epidemiology of HBV and HCV infections: anticipating the consequences
Anca Trifan, Iasi, Romania

15.00-15.20 Perspectives of treatment and cure of HBV infection
Maurizia Rosana Brunetto, Pisa, Italy

15.20-15.40 How to manage HBV reactivation in immunosuppressed patients
Adrian Goldis, Timisoara, Romania

15.40-16.00 Hepatitis E and immunosuppression
Vito Cicinnati, Muenster, Germany

16.00-16.20 The management of HDV infection in clinical practice: the role of new HBV and HDV biomarkers and last therapeutic advances
Ferruccio Bonino, Pisa, Italy

 
16.20-17.00 Satelite Symposium MSD
The race for HCV elimination: how close we are?
Speakers: Andrada Seicean, Cluj-Napoca, Romania; Liana Gheorghe, Bucharest, Romania

 
17.00-17.20  Coffee Break and Poster Viewing
 

17.20 -18.45 Parallel Case-based Workshops

Workshop 1:
Non-invasive assessment of liver fibrosis in clinical practice
Invited chair: Corina Pop, Mona Munteanu, Roxana Sirli
Presenters: Mona Munteanu, Horia Stefanescu, Corina Pop, Roxana Sirli

Workshop 2:
Management of cholestatic and autoimmune liver diseases
Invited chair: Susanne Beckebaum, Iulia Simionov, Andrada Seicean
Presenters: Iulia Simionov, Razvan Cerban, Carmen Ester

Workshop 3:
Harmful outcomes of DAA therapy
Chair: Speranta Iacob, Ciprian Brisc, Alina Tantau
Presenters: Carmen Preda, Alina Tantau, Larisa Sandulescu

 Workshop 4
Therapeutic endoscopy in liver cirrhosis
Chair: Eugen Dumitru,  Cristian Gheorghe, Carol Stanciu
Presenters: Eugen Dumitru, Ofelia MosteanuCristian Gheorghe 

 
18.45 Dinner
 

 

27 April 2018 Best Practices in Liver Cirrhosis and Hepatocellular carcinoma

 

8.30-10.10 End-stage liver disease and transplantation
Chair: Anca Trifan, Miguel Navasa

8.30-8.50 Prevention and treatment of variceal hemorrhage
Marcel Tantau, Bucharest, Romania

8.50-9.10  How to improve the long term outcome after liver transplantation?
Speranta Iacob, Bucharest, Romania

9.10-9.30 Role of statins and Rifaximin in portal hypertension
Cristina Cijevschi, Catalina Mihai, Iasi, Romania

9.30-9.50 Management of bacterial Infections in cirrhosis
Costica Aloman, Chicago, USA

9.50-10.10 Management of acute kidney injury in the pre- and the post-liver transplantation
Miguel Navasa, Barcelona, Spain

 
10.10-10.35 Coffee Break and Poster Viewing
 

10.35 – 11.20 Satellite Symposium Gilead
HCV patients populations with challenging treatment decision
Speakers: Liana Gheorghe, Bucharest, Romania; Speranta Iacob, Bucharest, Romania

 
11.20-13.30 Liver tumors: the role of a multidisciplinary team
Chair: Costica Aloman, Markus Peck-Radosavljevic

11.20-11.40 Basic approach of liver nodule(s)
Bogdan Procopet, Cluj-Napoca, Romania

11.40-12.00 Cross-sectional imaging (CT and MRI) in benign liver tumors
Ioana Lupescu, Bucharest, Romania

12.00-12.20 Is this a hepatocellular adenoma? Classification, diagnostic work-up and management
Zeno Sparchez, Cluj-Napoca, Romania

12.20-12.40 Advances in the loco-regional therapy of hepatocellular carcinoma
Mugur Grasu, Bucharest, Romania

12.40-13.00 Systemic and immunotherapy for advanced hepatocellular carcinoma
Markus Peck-Radosavljevic, Klagenfurt, Austria

 
13.00 – 14.00 Lunch
 

14.00-14.30 Satellite Symposium BMS
Impact of long-term NUCs therapy on the virological and clinical outcome of chronic hepatitis B
Speaker: Liana Gheorghe, Bucharest, Romania
 

14.30-16.00  BEST OF EASL: UpDate your clinical practice
Chair: Anca Trifan, Liana Gheorghe

Introduction

14.30-14.55  Vascular diseases of the liver
Pierre-Emmanuel Rautou, Clichy, France

14.55-15.20 Cholestatic liver diseases
Pietro Invernizzi, Monza, Italy

15.20-15.55 Alcohol-induced liver disease
Aleksander Krag, Odense, Denmark

Wrap-up

 
16.00 Closing and (Poster) Awards